Corporate Website
Africa
Argentina
Asia
Australia
Belgium
Brazil
Bulgaria
Canada (EN)
Chile
China
Colombia
Denmark
Egypt
France
Germany
Greece
Hungary
Indonesia
Italia
India
Japan
Korea
Malaysia
Mexico
Middle East
Netherlands
Peru
Philippines
Poland
Portugal
Romania
Russia
South Africa
Spain
Sweden
Thailand
Tunisia
Turkey
Ukraine
United Kingdom
USA
Vietnam
Your search for "result" return 76 results.
CEVAC® CORYMUNE 4K & 7K >
Benefits Beyond Protection
Hyogen® with ImuvantTM - Superior Protection Against Mycoplasma hyopneumoniae infection >
- Single injection provides early and long lasting protection - Broad stimulation of the immune system with ImuvantTM - Trials demonstrate superior protection versus competitors - Expertise of the...
VETRIMOXIN® LA - Technical profile >
Vetrimoxin® LA is the leading product in the Ceva anti-infective range. Within the group of historical antibiotics, the product has an extensive experience in the market as leader in its segment being...
C.H.I.C.K. Program Online - No.17 >
Vaccination in the hatchery - The assurance of a good start
Overview of porcine immune defenses and immunity to Mycoplasma hyopneumoniae infection >
The pig relies on multiple defenses to protect itself against microbial invasion. Understanding these immune defenses will help the producers to find the suitable solution to control the diseases in p...
C.H.I.C.K. Program Online - No.16 >
Hatchery vaccination - Toward a full control of vaccine administration
Ceva Lung Program - Overview >
The Ceva Lung Program (CLP) provides an overview of the diseases associated with Actinobacillus pleuropeumoniae, Mycoplasma hyopneumoniae and Aujeszky’s disease virus.
C.H.I.C.K. Program Online - No.15 >
Incubation and hatching processes - Main factors affecting the hatchability
Mycoplasma hyopneumoniae: strain diversity and control measures >
Control measures for infections with Mycoplasma hyopneumoniae should focus on optimisation of management practices, and if these are not sufficient, antimicrobial medication and/or vaccination can be...
Part 2 >
Actinobacillus pleuropneumoniae